BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹220 Cr | ₹203 Cr | ₹209 Cr | ₹166 Cr | ₹153 Cr |
What is the latest Total Current Liabilities ratio of BAL PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹220 Cr |
| Mar2024 | ₹203 Cr |
| Mar2023 | ₹209 Cr |
| Mar2022 | ₹166 Cr |
| Mar2021 | ₹153 Cr |
How is Total Current Liabilities of BAL PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹220 Cr | 8.10 | |
| Mar2024 | ₹203 Cr | -3.00 | |
| Mar2023 | ₹209 Cr | 26.38 | |
| Mar2022 | ₹166 Cr | 8.60 | |
| Mar2021 | ₹153 Cr | - | |
Compare Total Current Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹144.6 Cr | 3.2% | 14.1% | -7.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 3.2% |
14.1% |
-7.9% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses